CSS
CERE

Cubist Systematic Strategies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Cubist Systematic Strategies’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72,546
Closed -$2.97M – 3644
2024
Q2 		$2.97M Buy
72,546
+46,473
+178% +$1.94M 0.02% 1083
2024
Q1 		$1.1M Sell
26,073
-28,902
-53% -$1.21M 0.01% 2090
2023
Q4 		$2.33M Buy
+54,975
New +$1.58M 0.02% 1405
2023
Q1 		– Sell
-6,085
Closed -$192K – 4579
2022
Q4 		$192K Sell
6,085
-27,122
-82% -$765K ﹤0.01% 3599
2022
Q3 		$938K Buy
+33,207
New +$989K 0.01% 2681
2022
Q1 		– Sell
-8,486
Closed -$275K – 3849
2021
Q4 		$275K Sell
8,486
-9,323
-52% -$329K ﹤0.01% 2854
2021
Q3 		$525K Buy
17,809
+17,709
+17,709% +$497K 0.01% 2004
2021
Q2 		$3K Sell
100
-300
-75% -$4.29K ﹤0.01% 2885
2021
Q1 		$5K Sell
400
-11,725
-97% -$172K ﹤0.01% 2789
2020
Q4 		$201K Buy
+12,125
New +$157K ﹤0.01% 2237

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Cubist Systematic Strategies's CERE Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 72,546 shares — an estimated $2.97M sold.

Cubist Systematic Strategies first reported a position in CERE in Q4 2020 and held it in 10 quarters. The position peaked at $2.97M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 72,546 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $2.97M.
  • Cubist Systematic Strategies first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Cubist Systematic Strategies's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.97M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.